Letter by Braillon Regarding Article, “Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting”
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
Natarajan et al1 must be commended for providing the number needed to treat when analyzing the prevention of 1 coronary heart disease event according to genetic risk. However, they did not express it with a time frame.
According to Table 3 in their article,1 the number needed to treat during 1 year to avoid …